Exhibit 10.18
Confidential Materials omitted and filed separately with the
Securities and Exchange Commission. Asterisks denote omissions.
SUPPLY AGREEMENT
EIR MEDICAL, INC., a company organized and existing under the laws of
Massachusetts having offices at Xxxxxxxxxxxxxx. 0, 00000 Xxxxxxx, Xxxxxxx
(hereinafter referred to as "EIR").
NxStage Medical, Inc., a company organized and existing under the laws of
Delaware having offices at 000 Xxxxx Xxxxx Xxxxxx, Xxxxxxxx, XX 00000 (hereafter
referred to as "NxStage").
and
MEMBRANA GMBH, a company organized and existing under the laws of Germany having
offices at Xxxxxx Xxx. 00, X-00000 Xxxxxxxxx, Germany (hereinafter referred to
as "Membrana").
WHEREAS, Membrana is engaged, inter alia, in the manufacture and sale of
membranes for medical applications, in particular capillary membranes for
hemodialysis, and is interested in selling such membranes to EIR;
WHEREAS, EIR is a medical products company and is engaged, inter alia, in the
ESRD therapy business and intends to manufacture, among other things,
hemofilters with capillary membranes and, therefore, is interested in purchasing
capillary membranes from Membrana for incorporation into such filters.
NOW, THEREFORE, the parties have agreed upon the following:
Article 1: Scope of the Agreement
This Agreement shall govern all deliveries from Membrana to EIR of all blood
contacting capillary membrane types for renal replacement therapy ("Products"),
including without limitation, hemofiltration, hemodialysis, ultrafiltration and
hemodiafiltration, that can be made available to EIR, especially including
SYNPHAN(R) HF 600T and PUREMA(R) H capillary membranes as specified in the data
sheets attached hereto in ANNEX I, Sheet no. 080/0105/000 and the "Specification
for Primary Bundles", Sheet no. 080/0000/000 for SYNPHAN (collectively, the
`SYNPHAN Specifications'), Sheet no. 084/0126/000 and the `Specification for
Primary Bundles,' Sheet no. 084/0000/000 for PUREMA (collectively, the "PUREMA
Specifications"). Membrana shall notify EIR in writing of any change which may
have an effect on the following aspects of the Products: (i) SYNPHAN
Specifications, (ii) PUREMA Specifications, or (iii) any material change to the
quality control system or manufacturing process.
Article 2: Specification of Bundles
Membrana shall produce SYNPHAN and PUREMA bundles for EIR according to the
specifications listed below and attached hereto as ANNEX II:
Specification Fiber Bundle SYNPHAN(R) HF600T S-108
Specification Fiber Bundle PUREMA(R) H S-119
The parties may agree to modify the above specifications and/or add additional
specifications, according to EIR's needs and Membrana's capabilities. In case of
a switch to a new specification, EIR shall commit to order all bundles that have
been produced by Membrana pursuant to confirmed and accepted purchase orders.
If other dialysis membrane types in addition to SYNPHAN HF 600T or PUREMA will
be supplied by Membrana to EIR, then a signed supplement will be added to this
Agreement before the first shipment of such membranes, detailing pricing and
membrane specifications. All other terms of the Agreement will remain unchanged.
Article 3: Prices
3.1 The parties agree on the following volume discounted price schedule for
SYNPHAN HF 600T and PUREMA bundles.
Annual Volume,
(Calendar Year)
Km of SYNPHAN
HF 600T and/or Average Price
PUREMA (x 10/\-6) [euro/km]
----------------- -------------
[**] [**]
[**] [**]
[**] [**]
[**] [**]
For purposes of calculating prices under this table "purchases" will be
calculated as the sum of kilometres invoiced during one calendar year less
any returned material for which a refund has been given.
The final price for annual volumes is calculated via linear interpolation
[**], rounding volumes to the closest 1,000 kilometers. The resulting
price will be rounded to two decimal places (i.e., hundredths of Euro).
In other words, the adjusted price will be equal to the price associated
with [**] associated with the [**], by (b) the quantity obtained by
dividing (i) [**] by (ii) [**].
For illustration and by way of example only, if actual annual volume
equals [**] km, then the average price for purchases will be:
2
[**] = actual price
or
[**]At the conclusion of the calendar year, when all invoices have been
made out, the cumulative annual volume will be determined and the
foregoing calculation shall be made by Membrana and communicated in
writing to EIR by January 31 of the following year. If EIR's total
kilometers of SYNPHAN(R) and/or PUREMA purchased for the year exceed the
amount used to set the invoice price for that year, then Membrana shall
pay EIR a refund so that EIR's total purchase expenditure is made equal to
the expenditure that would have occurred if the price for the actual
volume had been invoiced all year. Such payment shall be made by February
28 of the following year. Conversely, if EIR's total kilometers of
SYNPHAN(R) and/or PUREMA purchased are less than the quantity used to set
the invoice price, then EIR shall pay Membrane a refund so that EIR's
total purchase expenditure is made equal to the expenditure that would
have occurred if the price for the actual volume had been invoiced all
year. Such payment shall be made by February 28 of the following year.
3.2 Net Invoice Pricing
Each year in November an agreement will be made on invoice price for the
following year. The price is set according to the pricing table above
(paragraph 3.1), and the volume reasonably and jointly expected for the
following year.
At the end of each calendar quarter (ending March 31, June 30, September
30 and December 31) the invoice price will be revised under consideration
of (a) the actual quantities purchased by EIR and (b) the parties'
estimate of EIR's purchases over the balance of the year.
Each month EIR shall provide Membrana with a non-binding forecast
indicating its demand for the next three months.
The delivered volume per bundle type may exceed or fall below the
ordered/confirmed amount by [**]%. The quantity actually delivered will be
invoiced.
If Membrana cannot meet EIR's requirements for any reason, and EIR has
placed the corresponding orders in time as per article 4 and MEMBRANA has
accepted these orders for production and has informed EIR about the
scheduled shipping date as per article 4, Membrana will reserve production
capacity for EIR according to the ratio between EIR's total annual
purchase volume and the total annual purchase volume of Membrane's other
customers for SYNPHAN(R) HF600T and PUREMA.
3
Article 4: Payment and Delivery Terms
4.1 Products shall, be ordered by EIR under a purchase order. EIR shall send
the purchase orders at least [**] before shipment date, indicating the
membrane type, bundle specification, number of bundles, and the requested
shipping date.
4.2 Membrana will send EIR an order confirmation accepting the details of the
relevant order and providing a definite date of shipment. Membrana shall
accept and timely supply all orders that are within the volumes forecasted
for the period by EIR. Membrana shall use its best efforts to accept and
timely supply all orders in excess of EIR's forecasted amount for the
period or requesting delivery in less than [**] from the order date, and
shall notify EIR in writing if Membrana anticipates that it will not be
able to satisfy such orders by the delivery dates indicated.
4.3 Accepted purchase orders may be cancelled by EIR at any time prior to
Product production for the order. If EIR sends notice of an order
cancellation, Membrana shall use best efforts to ensure that Product
production is promptly stopped with respect to that order.
4.4 EIR shall effect the payment of the purchase price in Euro as follows:
Payment shall be made within [**] after date of invoice, net. Payment
shall be made by wire transfer to Membrana's account [**]. Taxes and
duties, if any, will be borne by EIR in accordance with German Law.
4.5 All deliveries shall be effected free carrier (as defined in the Incoterms
2000 of the International Chamber of Commerce) at Membrana's premises in
Wuppertal. Packaging shall be included in the price.
4.6 EIR shall duly examine all deliveries of membrane bundles received for any
apparent defects. In case there should be any reason for complaints, EIR
shall notify MEMBRANA of such complaint in writing within [**] after the
respective installment of membrane bundles has been received; in case of
hidden defects notice of complaints shall be given by EIR immediately
after discovery, but no later than the expiration date of the finished
dialyzer. In its notice, EIR shall specify the quantity found defective,
the corresponding invoice, packing units, fabrication numbers and
production days of the bundles in question. EIR makes no representation
that it will inspect all bundles delivered and Membrana understands that
it is fully responsible for ensuring that its bundles meet the
Specifications. EIR agrees that Membrana shall not be responsible for
defects to membranes caused directly by EIR's manufacturing processes.
4.7 Membrana shall reimburse EIR for the cost of replacing all finished
products into which Membrana out-of-Specification fibers have been
incorporated and shall replace all out-of-Specification bundles not yet
incorporated into finished product. In addition, Membrana shall reimburse
EIR for all recall expenses incurred by EIR or its affiliates relating to
products incorporating out-of-Specification fibers, up to the amount of
double the net invoice sum for the delivery(ies) containing
out-of-Specification fibers.
Article 5: Retention of Title
4
5.1 Title to the membrane bundles supplied by Membrana shall remain with
Membrana until the purchase price for such bundles has been paid in full.
EIR may not pledge or give a security interest in bundles supplied by
Membrana until the purchase price has been paid in full.
5.2 EIR may sell products incorporating the bundles in the ordinary course of
its business before payment has been made in full. EIR hereby assigns to
Membrana all future rights and claims towards EIR's customers resulting
from the sales of products incorporating Membrana bundles for which the
purchase price has not yet been paid in full; provided that (a) EIR shall
have no obligation to notify its customers of this assignment unless it is
in payment default for a period of [**] following written notice from
Membrana, and (b) Membrana agrees that it shall not exercise any rights
against such customers until providing EIR [**] prior written notice of
the payment default and its intent to recover against customers. Membrana
shall exercise no rights against such customers in the event payment is
made within [**] of this notice.
5.3 EIR is entitled to collect the proceeds of products sold incorporating
Membrana bundles, which proceeds shall, to the extent of, and in the event
the purchase price therefore has not yet been fully paid by EIR, become
ipso jure property of Membrana, and which shall be held by EIR separately
from other means of payment for Membrana's benefit until payment in full
of the purchase price has been made. Thereafter, all rights of Membrana in
such proceeds shall be void.
5.4 In the event Membrana's retention of title loses its validity, EIR shall
be obligated to grant Membrana, without delay, reasonable security for the
bundles not yet paid for.
5.5 EIR shall obtain commercially reasonable insurance for bundles subject to
retention of title to cover any loss of such bundles, and shall provide
Membrana a certificate of this insurance coverage upon its request.
5.6 In the event EIR does not pay for the bundles within [**] of written
notice of a payment default, or if EIR becomes insolvent, EIR must, at the
request of Membrana, surrender the bundles in its possession that are
subject to retention of title to Membrana. The taking back of goods
subject to retention of title does not constitute a termination of the
Agreement.
Article 6: Quality Data & Technical & Scientific Support, Regulatory Matters
6.1 Membrana shall provide EIR with each shipment of membrane bundles the `QC
Data List' and the `Attachment to QC-Specification' as shown by example in
ANNEX III. This shall include, among other things, a certification that
the membrane bundles meet the Specification, and that the Products have
been manufactured in accordance with applicable laws and regulations.
6.2 Membrana shall provide reasonable assistance to EIR in connection with all
regulatory filings made by EIR or its affiliates relating to products
incorporating the membranes supplied by Membrana. Membrana, however, shall
not be liable for any damages resulting from the given technical advice or
the provided assistance.
5
6.3 EIR and its representatives and affiliates shall get the opportunity with
prior written consent of Membrana, during regular business hours, to audit
Membrana's facilities where the membranes are manufactured, packaged and
stored and to make any further examination reasonably necessary to
ascertain compliance with the membrane Specifications and this Agreement.
6.4 Membrana shall give EIR immediate notice if Membrana becomes aware of any
defect or condition which in any way alters the membrane Specifications or
the quality of any of the membranes supplied.
6.5 Membrana shall trace and maintain records regarding the source and lot
number of each membrane shipment. These records shall be delivered to EIR
upon EIR's request or upon the termination of this Agreement.
6.6 Membrana shall promptly notify EIR of the occurrence of any regulatory
inspections and of any changes in regulatory status.
Article 7: Exclusivity
EIR and NxStage intend to purchase the majority, and potentially all, of their
blood-contacting ESRD therapy membranes from Membrana, and agree to work in good
faith with Membrana to preserve Membrane's position as the primary supplier of
blood-contacting ESRD therapy membranes for EIR and NxStage. Membrana, however,
acknowledges that EIR and NxStage may need to maintain alternative sources of
membrane supply in order to protect against supply shortfalls, membrane failures
or other potential disruptions in membrane supply, and that EIR and NxStage may
obtain such supply without penalty hereunder.
Article 8: Confidentiality, Intellectual Property, Infringement Matters
8.1 EIR and NxStage shall keep strictly confidential any information disclosed
by Membrana during the term of this Agreement which is confidential by
nature or expressly marked as confidential, and Membrana will keep
strictly confidential all information disclosed by EIR or NxStage during
the term of this Agreement which is confidential by nature or expressly
marked as confidential. Without limiting the foregoing, Membrana shall
treat the purchase orders of EIR as strictly confidential, especially
prices, quantities and membrane specifications. The Parties' obligations
to keep information confidential shall survive for [**] following the
termination of this Agreement.
For purposes of this Agreement, confidential information shall not include:
- Information, which was, or becomes, in the public domain through no
fault or action of the non-disclosing party;
- Information which was already known by the non-disclosing party, as
shown by its written records;
- Information which becomes known by the non-disclosing party from a
third party not under an obligation of confidentiality to the
disclosing party; and
- Information which is independently developed by the non-disclosing
party.
6
8.2 All ideas, developments and inventions made or conceived by Membrana
during the term of this Agreement and for [**] thereafter which relate to
EIR's or NxStage's confidential information or which are made or conceived
by Membrana jointly with representatives of EIR or NxStage shall be the
sole and exclusive property of EIR.
8.3 Membrana represents and warrants that it is not aware of any third party
patent rights which could be infringed by SYNPHAN HF600T or PUREMA. In the
event that such a right is asserted against either party, however, the
respective party shall immediately inform the other party and both parties
shall discuss subsequent actions.
(a) If after due evaluation Membrana or EIR decides to reduce or stop
the supply or use of SYNPHAN HF600T or PUREMA in compliance with
such assertion, then Membrana will buy back from EIR unused
inventories of SYNPHAN HF600T or PUREMA, s the case may be, at the
same price as EIR has paid for SYNPHAN HF600T or PUREMA,
respectively.
(b) If the parties agree to continue the supply and use of SYNPHAN
HF600T or PUREMA in spite of such an assertion, they shall jointly
organize their defense and shall agree on a fair sharing of costs
required for an appropriate defense.
Article 9: Liability
9.1 Membrana shall not be liable for representations made during contract
negotiations, including without limitation, for incorrect advice given to
EIR or NxStage during such negotiations.
9.2 If Membrana gives technical advice to EIR or NxStage without respect to
the processing or treatment of bundles, it is agreed that such advice is
given without any liability on Membrana.
9.3 Without limiting the foregoing, Membrana shall not be liable for minor
violations of the Agreement which do not result in material harm to EIR or
NxStage or physical injury to a person (it being specifically understood
without limitation that the delivery of out-of-Specification bundles shall
not constitute a minor violation of the Agreement), unless such minor
violations are the result of Membrana's or its agents' or affiliates'
gross negligence or willful misconduct.
9.4 In no event shall either party be liable to the other party under this
Agreement for any consequential, incidental, special or other indirect
damages arising under this Agreement.
9.5 Each party ("the Indemnifying Party") agrees to indemnify and hold the
other party (the other party and its affiliates and the officers,
employees and directors of the other party and its affiliates,
collectively hereinafter referred to as the "Indemnified Party") harmless
from any and all third party claims, damages, costs and expenses that may
be claimed or asserted against the Indemnified Party, arising out of the
negligence of the Indemnifying Party in performing its obligations
hereunder, the breach of the Indemnifying Party of
7
any terms hereunder, or the supply of a defective product or component by
the Indemnifying Party hereunder. The obligation of the Indemnifying Party
to indemnify the Indemnified Party pursuant to this Section shall be
conditioned upon the Indemnified Party giving reasonably prompt notice of
any such claim for indemnification to the Indemnifying Party, and giving
the Indemnifying Party authority to conduct the defense of any action;
provided, however, that the Indemnified Party may retain additional
counsel at its own expense and participate in any such litigation.
Article 10: Term
This Agreement shall enter into force upon signature of the last signing party
and shall remain valid for four years.
This Agreement may be renewed for an additional term, subject to the mutual
written agreement of the parties. Either party shall have the right to terminate
this Agreement if the other party breaches any of its obligations under this
Agreement and fails to cure such breach within [**] of receiving written notice
from the non-breaching party. In addition, EIR shall have the right to terminate
this Agreement in the event Membrana materially fails to perform its supply
obligations hereunder for a period of at least [**], including without
limitation, failures due to a continued force majeure event. In case of
termination of this Agreement all confirmed orders have to be fulfilled and to
be paid for.
Article 11: Representations and Warranties
11.1 EIR and Membrana each hereby represent and warrant as follows:
11.1.1 It is a corporation duly organized, validly existing and in good
standing under the laws of the jurisdiction of its incorporation
and has the full corporate power and authority to enter into this
Agreement and perform its agreements and covenants to be performed
hereunder.
11.1.2 The execution and delivery of this Agreement and its performance of
the covenants and agreements hereunder have been duly authorized by
all necessary corporate action and, when executed and delivered,
shall be valid and binding upon it.
11.1.3 Neither the execution and delivery of this Agreement nor the
performance by it of the transactions contemplated herein will
violate any provision of its certificate of incorporation or bylaws
or any rule, law, regulation, judgment, decree or other order of
any court, government, or governmental agency or instrumentality,
or conflict with or result in any breach of any of the terms of, or
the creation or imposition of any charge or encumbrance pursuant
to, any contract or agreement to which it is a party or by which
it, or any of its assets and properties are bound.
8
11.2 Membrane warrants that the bundles delivered to EIR under this Agreement
shall comply with the Specifications.
Article 12: Choice of Law, Arbitration
12.1 All disputes arising in connection with this Agreement shall be finally
settled under the Rules of Conciliation and Arbitration of the
International Chamber of Commerce by one or more arbitrators appointed in
accordance with said rules and according to German Law. Venue shall be
Dusseldorf, Germany; language of the arbitration shall be English.
Article 13: Force Majeure
13.1 Neither Membrana nor EIR shall be liable for any failure to perform under
this Agreement, including any failure or delay in delivering Products,
that is caused by an event of force majeure. For purposes hereof, force
majeure shall mean any cause beyond Membrana's or EIR's reasonable
control, including, but not limited to, acts of God, war, riots, flood,
fire, explosion, strikes, lock-out and epidemic.
Article 14: Miscellaneous
14.1 EIR shall have the right to market and advertise products incorporating
membranes supplied by Membrana under EIR's or its affiliates' name,
trademarks, labels or other designations and the same shall remain the
sole and exclusive property of EIR or its affiliates. In addition, EIR and
its affiliates shall have the right to reference Membrana's name and logo
on EIR's or its affiliates' products Incorporating Membrane fibers in
accordance with this Supply Agreement, with Membrane's prior written
consent, which shall not be unreasonably withheld.
14.2 If any provision of this Agreement should become invalid this shall in no
way interfere the validity of the remaining provisions. The parties will
replace the provision declared invalid by another provision coming the
closest possible to the provision declared invalid.
14.3 Membrana's General Conditions of Sale, in the form attached hereto as
ANNEX IV, shall apply to all sales of membranes hereunder provided that if
such conditions of sale conflict with any terms hereunder, the terms of
this Agreement shall govern. Notwithstanding the foregoing, the parties
agree that [**] shall not apply to sales of membranes hereunder or to EIR
under this Agreement.
14.4 The rights and obligations under this Agreement shall not be assignable
without the prior written consent of the other party. Notwithstanding the
foregoing, the terms of this Agreement shall survive a change-in-control
of either party; provided that any successor or acquirer of EIR or
Membrane may terminate this Agreement upon 12 months prior written notice
within the first 12 months following any such change-in control of EIR or
Membrana.
14.5 Any modifications of this Agreement must be in writing.
9
14.6 This Agreement constitutes the entire agreement between EIR and Membrana
and supersedes any previous agreement between the parties relating to the
subject matter of this agreement.
EIR Medical, Inc. Membrana GmbH
By: /s/ Xxxxxxx Xxxxxxx By: /s/ Xxx Xxxxxx
Xxxxxxx Xxxxxxx Xxx Xxxxxx
Lawrence, MA September 30, 2004 Wuppertal, October 25, 0000
Xxxxxxx Xxxxxxx /x/ Xxxxxxx Xxxxxxx
Xxxxxxxxx, XX October 1, 2004
REVIEWED AND AGREED:
NxStage Medical, Inc.
By: /s/ Xxxxxxx Xxxxxxx
Xxxxxxx Xxxxxxx
Lawrence, MA September 30, 2004
10
ATTACHMENTS
Annex I Specifications for SYNPHAN and PUREMA Dialysis Membranes
Four (4) pages of Confidential Materials omitted and filed separately
with the Securities and Exchange Commission.
11
Annex II Specification for SYNPHAN and PUREMA Fiber Bundles
Three (3) pages of Confidential Materials omitted and filed separately
with the Securities and Exchange Commission.
12
Annex III QC Data and QC Data List Examples (SYNPHAN and PUREMA)
Two (2) pages of Confidential Materials omitted and filed separately
with the Securities and Exchange Commission.
13
Annex IV MEMBRANA General Terms and Conditions
14
MEMBRANA
Underlining Performance
Conditions of Sale
GENERAL CONDITIONS OF SALE OF MEMBRANA GMBH
I. EXCLUSIVE VALIDITY OF OUR CONDITIONS OF SALE
All of our quotations and tenders are based on our General Conditions of Sale.
We accept purchase orders exclusively on these terms. General terms and
conditions of the purchaser or agreements deviating from our Commercial Code
shall be binding on us only if we expressly recognise them in writing. With the
placing of an order or the acceptance of work of services the purchaser
recognises the validity of our General Terms and Conditions not only for the
business transaction in question, but also for all future business transactions.
II. AREA OF APPLICATION
Our General Terms and Conditions shall apply only to legal transactions with
companies in the sense of the German Civil Code.
III. DELIVERY
1. As soon as the goods leave our works or our warehouse or are made available
to the Buyer ready for shipping in a manner establishing default in acceptance,
all transport risks shall pass to the Buyer.
2. Periods and deadlines agreed upon for our services and work shall only be
deemed to be binding, if they are expressly designated as such by us. A delivery
period or a delivery date shall be deemed to have been adhered to, if the goods
have left our works or our sales warehouse by the expiry of the period.
3. Force Majeure and other obstructions which are beyond our control such as
war, mobilisation, fire, strike and lockout and suchlike shall exempt us, for
the duration of such disturbance and its consequences, from the obligation to
deliver. Should such circumstances occur, after we have defaulted, the
consequences of default shall remain excluded for the duration of their
effectiveness. If the delivery period agreed upon is exceeded by more than two
months, the Buyer and the Seller shall be entitled to cancel the part of the
contract not performed.
4. The Buyer must, if the delivery period is exceeded, set a reasonable
extension of the period in writing. If we have not performed the work or service
within this additional period, the Buyer shall be entitled to cancel the
contract.
15
5. From the exceeding of a period for performance or a performance date or from
performance default the Buyer shall not be entitled to derive any claims for
damages against us, unless the exceeding of the period or deadline is due to
wilful intent or gross negligence on the part of one of our statutory
representative or of one of our vicarious agents.
6. We shall be entitled to effect part deliveries and to invoice each part
delivery in itself, as far as a part delivery is tolerable for the Buyer. The
re-sale of the goods delivered using make-up and packaging material owned by us
shall require our prior written consent.
7. Seller may deliver against any order an excess or deficiency of up to 10 % of
the quantity ordered. The quantity actually delivered will be invoiced.
IV. PAYMENT
1. Besides the prices agreed, the Buyer must pay the statutory value-added or
turnover tax at the currently applicable rate.
2. Retention of due payments or offsetting shall be possible only on the basis
of claims of the purchaser which have been the subject of non-appealable court
decisions or have been recognised by us in writing.
3. All costs arising in connection with the contract in the country of the Buyer
including fees and taxes which were not known at the time of the conclusion of
the contract shall be borne by the Buyer.
4. If, after the conclusion of the contract, circumstances come to our knowledge
which appear to make the credit worthiness of the purchaser doubtful, we can, at
our discretion, demand cash in advance or provision of securities.
5. In case of late payment by Buyer, Buyer shall, without prejudice to any other
right of Seller, be liable to pay interest at a yearly rate of 8 % in excess of
the basic interest rate (Euribor).
V. RETENTION OF TITLE
1. The goods supplied by us shall remain our property up to the complete
settlement of all of our receivables from the reciprocal business relationship
including any possible current account balance. The goods may not be pledged to
others or transferred as security.
2. Should we as a result of a combination of the goods supplied by us with the
goods of the purchaser not acquire co-ownership, but lose our property, the
ownership or co-ownership of the Buyer of the new item shall immediately pass to
us upon its creation. All expectant rights which could lead to such an
acquisition of ownership or co-ownership by the Buyer, are now already assigned
to us by the latter. Any possible transfer necessary by us for the acquisition
of the ownership or co-ownership shall be replaced by the agreement that the
party ordering the goods preserves the item for us like a borrower, or, if the
party ordering a good does not own the item, by
16
the assignment of the entitlement to surrender against the owner to us already
agreed hereby. The ownership or co-ownership arising for us is to be treated
legally like the original goods. Otherwise the goods supplied by us and subject
to retention of title are also to be treated with care.
3. If the Buyer, despite default, does not pay or if the Buyer threatens to
become insolvent, the Buyer must, at our request, surrender the goods subject to
retention of title for our free disposal. The taking-back of goods subject to
retention of title does not constitute any cancellation of the contract.
4. All receivables of the Buyer from re-sale of goods of which we have ownership
or coownership (goods subject to retention of title) shall already pass to us
upon the conclusion of the transaction of sale. This shall apply whether the
goods are sold to one or to several customers. The purchaser must collect the
receivables assigned. We can revoke this authority, if the purchaser does not
punctually meet one of his obligations towards us or if circumstances come to
our knowledge which make our rights appear threatened.
5. We undertake, at the request of the Buyer, to release the securities (goods
and accounts receivable) to which we are entitled according to the above rules
at our discretion, if their value exceeds the claims to be secured by more than
20 %. For the valuation of the security their realisable value (securing value)
is decisive.
6. If our retention of title loses its validity in the case of supplies abroad
or for other reasons, the purchaser shall be obliged to grant to us without
delay security for the items supplied or any other security for our accounts
receivable which will be effective according to the law applicable in each case
and come as close as possible to the retention of title according to German law.
7. The Buyer shall be obliged to insure the goods subject to retention of title
with the due care and diligence of a prudent businessman and on request to
provide evidence to the effect that this insurance has been taken out. The Buyer
already now assigns to us his claims under this insurance by way of security.
VI. INCOTERMS
The usual commercial terms such as FOB and CIF shall apply in accordance with
the INCOTERMS of the International Chamber of Commerce in the version as of the
conclusion of the contract.
VII. CLAIMS CONCERNING DEFECTS
1. Notices of defects must be sent in writing at the latest within 30 days of
receipt of the goods - in the case of hidden defects without delay after their
discovery - stating the invoice and packaging unit. Deviations with regard to
the raw or colour shade of the goods supplied shall not be deemed to be
17
defects, unless they lead to a considerable deterioration in the usability of
the products made therefrom.
2. In the case of notices of defects sent in good time and justifiably we shall,
at our discretion, have the right to reduce the purchase price by a reasonable
amount or to supply a replacement. In the event of a failed delivery of
replacement the purchaser shall have the choice between repeat delivery of a
replacement, reasonable reduction of the price and returning of the goods after
the refunding of the purchase price. Defects in one part of our performance
shall not entitle the Buyer to complain about the performance as a whole.
3. If the Buyer wishes to further process the goods despite identifiable
defects, he shall give us an opportunity to make comments in good time prior to
this.
4. Claims of the purchaser based on defects shall be subject to the statute of
limitations 12 months after the delivery of the goods.
5. Our warranties shall expire, if the goods are modified by others, moreover,
our warranty shall expire, if the Buyer does not follow our instructions for
use.
VIII. LIABILITY
1. For consequences
a) of errors which occur during contract negotiations, in particular for the
consequences of inadequate or incorrect advice given to the Buyer,
b) the violation of non-essential contractual duties (subsidiary duties), for
example a consulting or protection obligation,
c) an unlawful act, unless it consists of injury for life and limb or the
impairing of the health of the Buyer, we shall only accept liability if these
consequences are due to wilful intent or gross negligence of one of our
statutory representatives or one of our vicarious agents.
2. Should the Buyer suffer disadvantages as a result of the fact that we violate
non-essential contractual obligations (subsidiary obligations), for example a
consulting or protection obligation, we shall likewise only accept liability if
these consequences are due to wilful intent or gross negligence of one of our
statutory representatives or one of our vicarious agents.
3. For consequences, as long as they do not consist of injury of life and limb
or the impairing of the health of the Buyer, or unlawful acts which one of our
statutory representatives or one of our vicarious agents commit, we shall only
accept liability if these consequences were brought about by wilful intent or
gross negligence.
4. Where Seller gives technical advice to Buyer with respect to the processing
or treatment of the goods, it is agreed that such advice is given without any
liability on Seller's part.
IX. MAKE-UP AND PACKAGING MATERIAL
18
If the Buyer does not return make-up and packaging material which remains our
property within a time limit to be determined by us on the terms and conditions
laid down and in a state capable of being used we shall be entitled to invoice
the Buyer for the replacement price and to demand immediate payment for it. If
the Buyer provides evidence of damage considerably below the replacement price,
only this is to be refunded.
X. XXXXX AND SIGNS
Marks and signs under which the goods are supplied must not be used for the
products produced therefrom without our prior written consent.
XI. OTHER PROVISIONS
1. The sales contract shall be subject to German law. The use of the Convention
of the United Nations of 11.04.1980 concerning contracts on international
purchase of goods shall be excluded.
2. The exclusive venue for all disputes about and resulting from the contract
shall be Wuppertal. We shall, however, have the right to xxx the Buyer at any
other venue applicable to him.
3. Should any provision of this contract be or become ineffective, or should a
gap emerge in this contract, the effectiveness of the remaining provisions shall
not be affected by this.
4. In place of the ineffective provisions or in order to fill the gap a
reasonable provision shall be inserted which, as far as legally possible, comes
as close as possible to what the parties concluding the contract wanted or would
have wanted according to the sense and purpose of the contract, if they had
considered the point.
19
